Molomics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Molomics General Information

Description

Provider of drug design and discovery support services intended for structurally novel small molecule therapeutics. The company through its technology uses both artificial intelligence and human collective intelligence to collaboratively design high-potential drug candidates with diverse structures in real-time, enabling research institutes and organizations into the biotech and pharma industry to unlock new opportunities and to assure the design of efficacious and safer drugs.

Contact Information

Website
www.molomics.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Baldiri and Reixac 4-8
  • 08028 Barcelona
  • Spain
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Acquirer
VeriSIM Life
Vertical(s)
Artificial Intelligence & Machine Learning
Corporate Office
  • Baldiri and Reixac 4-8
  • 08028 Barcelona
  • Spain

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Molomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Molomics‘s full profile, request access.

Request a free trial

Molomics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Molomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3128451-A1 Method, computer program, video game and system for optimizing a molecule for medical applications Inactive 07-Aug-2015
US-20180239877-A1 Method, computer program, video game and system for optimizing a molecule for medical applications Inactive 07-Aug-2015
US-20230368871-A1 Method, computer program, video game and system for optimizing a molecule for medical applications Pending 07-Aug-2015
WO-2017025361-A1 Method, computer program, video game and system for optimizing a molecule for medical applications Inactive 07-Aug-2015 G16C20/50

Molomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Molomics FAQs

  • When was Molomics founded?

    Molomics was founded in 2015.

  • Where is Molomics headquartered?

    Molomics is headquartered in Barcelona, Spain.

  • What is the size of Molomics?

    Molomics has 3 total employees.

  • What industry is Molomics in?

    Molomics’s primary industry is Drug Discovery.

  • Is Molomics a private or public company?

    Molomics is a Private company.

  • What is Molomics’s current revenue?

    The current revenue for Molomics is .

  • When was Molomics acquired?

    Molomics was acquired on 11-May-2022.

  • Who acquired Molomics?

    Molomics was acquired by VeriSIM Life.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process